Definitive Contract 75A50124C00024

The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $618,200 firm-fixed-price contract to Bugseq Bioinformatics Inc. for the development of scalable sequencing approaches to detect novel pathogens. This contract, which has a completion date of January 31, 2024, was awarded under ASPR-22-00799, a solicitation issued under the Easy Broad Agency Announcement (EZ-BAA) from the Division of Research,...

This is a $2,474,747.75 fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of testing kits and panels for Bloodstream Infections, COVID-19, Meningitis/Encephalitis, and other infectious diseases. The contract has an ultimate completion date of April 29, 2026 and does not utilize a set-aside designation. Biofire Diagnostics LLC is an experienced federal contractor, holding several indefinite...

This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. The $24,800 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. No set-aside designations are noted. Illumina has previously received prime contracts and subcontracts from other federal...

This is a $630,976 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company headquartered in Redwood City, California. The contract is for research and development of metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. Karius, Inc. is a specialized provider of advanced molecular diagnostic testing and next-generation...

This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...

This is a Firm Fixed Price contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to Janus-I Science Inc., a self-certified small disadvantaged business. The contract, valued at $710,619.00, is for Direct RNA Sequencing of Emerging Respiratory Agents and Host Response, under the JANUS-I program. This contract was awarded on April 15, 2019, with a completion date of October 14, 2020. It was not set aside for any...

This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...

This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Acgt Inc., a for-profit organization and Asian-Pacific American owned Subchapter S corporation. The $88,465.00 contract is for sequencing services to support COVID-19 research. Acgt Inc. has previously provided similar services to NIAID as well as the U.S. Department of Agriculture's Animal and...

This federal contract award, valued at $85,340.00, was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Genedata (USA), Inc., a foreign-owned, self-certified small disadvantaged business. The contract provides for the software license, maintenance, and support of Genedata Screener, the company's proprietary bioinformatics software platform, to support critical research initiatives,...

This is a $4,469,522.01 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Agile Sciences, Inc., a small disadvantaged business. The contract is for "Targeting Therapeutics Development to Relieve Bottlenecks: Optimizing Lead Therapeutic Compounds Against Infectious Pathogens" and has an ultimate completion date of October 15, 2018. The contract was awarded on June 30, 2015 and was not set aside.